You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

40-GEP

Showing 26 - 50 of 8,967
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Australia (64Cu-SARTATE)

Recruiting
  • Neuroendocrine Tumors
  • Kingswood, New South Wales, Australia
  • +3 more
May 17, 2022

Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Trial in Cleveland (TQ Formula (black

Not yet recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Gastroenteropancreatic Neuroendocrine Neoplasm
  • TQ Formula (black seed oil capsules)
  • +2 more
  • Cleveland, Ohio
    University hospitals Seidman Cancer Center, Case Comprehensive C
Aug 12, 2022

Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lanreotide autogel
  • Sichuan, Chengdu, China
  • +13 more
Jan 16, 2023

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN

Recruiting
  • Neuroendocrine Tumors
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Apr 16, 2022

    Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Hamburg, Germany
    • +3 more
    Dec 16, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))

    Suspended
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Sep 21, 2022

    Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in

    Recruiting
    • Breast Cancer
    • GEP
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Dec 16, 2022

    NSCLC Trial in Beijing (Durvalumab, Albumin Paclitaxel, Carboplatin/Cisplatin)

    Recruiting
    • Non-small Cell Lung Cancer
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 21, 2022

    Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

    Not yet recruiting
    • Small Cell Lung Cancer (SCLC)
    • +3 more
    • (no location specified)
    Dec 7, 2022

    Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Little Rock, Arkansas
      University of Arkansas for Medical Sciences
    Sep 7, 2021

    Models in Neuroendocrine Neoplasm

    Recruiting
    • Neuroendocrine Neoplasm
    • Biopsy, open or laparoscopic surgery
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Sep 19, 2021

    Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

    Recruiting
    • Metastatic Digestive System Neuroendocrine Neoplasm
    • Metastatic Neuroendocrine Tumor
    • Phoenix, Arizona
    • +10 more
    Aug 23, 2022

    Cesarean Section, Intrathecal Morphine, Quality of Recovery 40 Trial (intrathecal morphine, intrathecal fentanyl)

    Not yet recruiting
    • Cesarean Section
    • +2 more
    • intrathecal morphine
    • intrathecal fentanyl
    • (no location specified)
    Oct 6, 2023

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

    Not yet recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Somatostatin analog
    • Brasschaat, Antwerp, Belgium
    • +19 more
    Jan 31, 2023

    Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)

    Completed
    Has Results
    • Neuroendocrine Tumors
    • +2 more
    • Fort Myers, Florida
    • +12 more
    Nov 16, 2021

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    68Ga-DOTATOC Radio-Guided Surgery With ß-Probe in GEP-NET

    Recruiting
    • Neuroendocrine Tumor Carcinoid
    • +2 more
      • Milan, Italy
        IRCCS Istituto Europeo di Oncologia S.r.l.
      Jul 8, 2022

      Cancer Trial in Heidelberg, Mainz (combination of Avelumab and Cabozantinib)

      Recruiting
      • Cancer
      • combination of Avelumab and Cabozantinib
      • Heidelberg, Germany
      • +1 more
      Mar 31, 2022

      Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

      Completed
      • Neuroendocrine Tumors
      • Innsbruck, Austria
        Department of Nuclear Medicine, Medical University of Innsbruck
      Nov 24, 2023

      Neuroendocrine Carcinomas Trial in France (Folfiri-bevacizumab, Folfiri)

      Recruiting
      • Neuroendocrine Carcinomas
      • Amiens, France
      • +26 more
      Jan 26, 2022

      Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

      Not yet recruiting
      • Neuroendocrine Neoplasia's (NENs)
      • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
      • Basel, Switzerland
        Division of Nuclear Medicine, University Hospital Basel
      Apr 27, 2022

      Gastro-entero Pancreatic Neuroendocrine Tumors Trial in Italy

      Recruiting
      • Gastro-entero Pancreatic Neuroendocrine Tumors
        • Rozzano, Milan, Italy
        • +35 more
        Oct 27, 2022

        Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

        Recruiting
        • Metastatic Well Differentiated Neuroendocrine Neoplasm
        • Neuroendocrine Tumors
        • Milano, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori
        Sep 3, 2021